Genertec Universal Medical Group Company Limited (5UM) — Cash Flow-to-Debt Ratio
Genertec Universal Medical Group Company Limited (5UM) has a Cash Flow-to-Debt Ratio of -0.03x as of June 2023, meaning its operating cash flow of €-1.67 Billion could theoretically repay 0% of its total liabilities (€64.56 Billion) in one year. See Genertec Universal Medical Group Company leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genertec Universal Medical Group Company Limited Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Genertec Universal Medical Group Company Limited across 10 annual periods. For the full cash flow conversion analysis, see 5UM cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Genertec Universal Medical Group Company Limited (2016–2025)
Year-by-year debt coverage analysis for Genertec Universal Medical Group Company Limited. Check 5UM cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | €5.78 Billion | €59.28 Billion | ▲ +440.7% |
| 2024 | 0.02x | €1.14 Billion | €63.16 Billion | ▼ -78.4% |
| 2023 | 0.08x | €4.99 Billion | €59.98 Billion | ▲ +131.4% |
| 2022 | 0.04x | €2.06 Billion | €57.17 Billion | ▲ +234.3% |
| 2021 | -0.03x | €-1.40 Billion | €52.28 Billion | ▼ -28.3% |
| 2020 | -0.02x | €-971.72 Million | €46.55 Billion | ▲ +49.2% |
| 2019 | -0.04x | €-1.82 Billion | €44.41 Billion | ▲ +73.5% |
| 2018 | -0.15x | €-5.73 Billion | €37.00 Billion | ▲ +7.6% |
| 2017 | -0.17x | €-5.07 Billion | €30.26 Billion | ▼ -57.6% |
| 2016 | -0.11x | €-2.38 Billion | €22.39 Billion | — |